Navigation Links
Therapies for spinal cord injury: On the cutting edge of clinical translation
Date:8/31/2012

Charlottesville, VA (August 31, 2012). The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online. The online version of the supplement is available free to the public. The focus of this special supplement, which was spearheaded by Dr. Michael Fehlings, Professor of Neurosurgery at the University of Toronto and Medical Director of the Krembil Neuroscience Centre at the Toronto Western Hospital, is the development of cutting-edge translational research in the treatment of spinal cord injury (SCI), an often devastating injury that affects 2.5 million people worldwide, many of whom are first faced with it in early adulthood. The topic is addressed in a variety of forms in 17 articles and several editorials.

Many of the studies were conducted by members of the North American Clinical Trials Network (NACTN) for the Treatment of SCI, a consortium of 10 neurosurgery departments supplemented by a data management center and a pharmacological center. The principal investigator for the NACTN is Dr. Robert Grossman, Chairman, Department of Neurosurgery, The Methodist Hospital, Houston. Funded by the Christopher and Dana Reeve Foundation and the US Department of Defense, the NACTN was established to move molecular- and cell-based discoveries in the protection and regeneration of neuronal pathways from the laboratory to the clinical setting.

The supplement brings together papers focused on a variety of subjects related to identifying and evaluating different types of SCI, as well as developing therapeutic strategies for dealing with the disabilities that attend the injury. Graded assessments used to define the scope and extent of injury are pr
'/>"/>

Contact: Gillian Shasby
gshasby@thejns.org
434-924-5555
Journal of Neurosurgery Publishing Group
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
2. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
3. By adding VSL#3 probiotic to traditional therapies UC patients can improve remission rates
4. Stem cell transplantation into mouse cochlea may impact future hearing loss therapies
5. Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis
6. Aging kidneys may hold key to new high blood pressure therapies
7. Neuroprotective dietary supplements for chronic spinal cord injury
8. New studies show spinal cord injury and ALS respond to cell transplantation
9. Low oxygen levels may decrease life-saving protein in spinal muscular atrophy
10. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
11. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013. Plastic additives known as phthalates ... everywhere: They turn up in flooring, plastic cups, ... the Centers for Disease Control and Preventionthe bodies ... have come under increasing scrutiny. A growing collection ... can leech from packaging and mix with food) ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Drugs found to both prevent and treat Alzheimer's disease in mice 2
... Institute is home to a rich trove of biological ... genetic Library of Congressholds over 147,000 plasmids, (circular DNA ... as well as full genome collections from numerous organisms ... A new $6.5 million grant from the National ...
... its initial appearance in New York in 1999, West Nile ... years and is now well established throughout North and South ... birds that are important hosts for the virus are abundant ... As a result, transmission of West Nile virus is highest ...
... (NSF) has awarded $3 million to Clemson University to ... sensors to monitor water quality along the entire length ... represents a ,big idea, worthy of Thomas Green Clemson, ... scientific research and education," said Clemson President James F. ...
Cached Biology News:Clearing house for DNA gets a boost 2Clearing house for DNA gets a boost 3West Nile virus transmission linked with land-use patterns and 'super-spreaders' 2West Nile virus transmission linked with land-use patterns and 'super-spreaders' 3Clemson's Intelligent River technology to provide real-time monitoring of river 2Clemson's Intelligent River technology to provide real-time monitoring of river 3Clemson's Intelligent River technology to provide real-time monitoring of river 4
(Date:5/21/2013)... 2013 Custom Learning Designs, Inc.(CLD) ... solution using Tin Can API combined with its ... is a leading developer of training content and ... worldwide. , Tin Can API is a ... and trainers more accurately measure the Return on ...
(Date:5/21/2013)... , May 21, 2013 ... Dialysis and Transplant Association) is the biggest congress in ... replacement therapy. Nearly 10,000 participants are in ... the latest research findings. New pioneering studies have been ... "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA ...
(Date:5/21/2013)... According to a new market ... "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, ... Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued ... to grow at a CAGR of 10.1% from 2012 ... 4.7 billion in 2018. Browse the full ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... Ortho Biotech is pleased,with recommendations of ... Renal Drugs Advisory Committee (CRDAC) and Drug ... from the,Committees, evaluation of the use of ... failure (CRF). "Ortho Biotech supports the ...
... 11 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ... Marcial of BusinessWeek, highlighted Access Pharmaceuticals in ... The article is also available,on http://www.BusinessWeek.com ... The article focused upon the major ...
... Additional Phase 3 Trials on Track for Initiation Later ... for Today at 8:30 a.m. Eastern Time -, ... ARNA ) announced today that an independent Echocardiographic,Data Safety ... to stop,the ongoing pivotal Phase 3 trial, BLOOM (Behavioral ...
Cached Biology Technology:Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients 2Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients 3Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients 4Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients 5Access Highlighted in Recent BusinessWeek Article 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 3Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 4Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 5Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 6
GlutaMAX-I Supplement...
... Dissociation Buffers are membrane-filtered isotonic and ... agents and cell-conditioning agents in either ... solution or Ca2+- and Mg2+-free ... mammalian cells from support substrates and ...
Goat polyclonal to PINX1 ( Abpromise for all tested applications). entrezGeneID: 54984 SwissProtID: Q548A5...
...
Biology Products: